Inflammatory pathway mediator in macrophage

The term "inflammatory pathway mediators in macrophages" refers collectively to the diverse set of molecules produced by or acting upon macrophages that regulate inflammation. These include pro-inflammatory cytokines like TNF-alpha and IL‑6; anti-inflammatory factors like IL‑10; chemokines that recruit other immune cells; lipid mediators such as prostaglandins; growth factors involved in tissue repair; and various cell surface receptors including Toll-like receptors that sense pathogens.[1][2] Macrophage activation states—commonly described along an M1 ("classically activated," pro-inflammatory) versus M2 ("alternatively activated," anti-inflammatory/tissue-repairing) spectrum—are determined by these signals.[1] The balance among these mediators shapes outcomes ranging from acute pathogen clearance to chronic inflammation or fibrosis.[5] Because this designation covers many distinct molecular entities rather than one defined protein/receptor/enzyme/transporter/etc., it should not be used as the canonical name for any single drug target.[3]

Other names

Macrophage inflammatory mediatorsMacrophage-derived cytokinesPro-inflammatory/anti-inflammatory factors in macrophages

Varies by mediator: - Cytokine blockade/inhibition reduces pro-inflammatory signaling. - Modulation of intracellular signaling cascades alters polarization between M1/M2 phenotypes. - Inhibition of efferocytosis receptors can reduce fibrosis or alter immune responses.